Formula: | C23H24ClN5O |
Molecular Weight: | 421.93 |
Rotatable Bond Donors: | 3 |
clogP: | 3.91 |
Topological Polar Surface Area: | 63.05 |
Lipinski's RO5: | MW: 421.93 HBA: 6 HBD: 1 RB: 3 LogP: 3.91 |
Rule of Three: | MW: 421.93 HBA: 6 HBD: 1 RB: 3 LogP: 3.91 |
|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC212373586 | 1.0 | ZINC212373586 RDKit 3D 30 34 0 0 0 0 0 0 0 0999 V2000 -7.0933 -3.4525 -0.4331 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.8101 -2.9867 0.0377 N 0 0 0 0 0 0 0 0 0 0 0 0 -5.2578 -1.7774 -0.2432 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.0557 -1.7485 0.4311 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.1132 -0.6546 0.4064 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.3350 0.4719 -0.3848 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.3975 1.5047 -0.4237 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.2130 1.4364 0.3189 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2144 2.5118 0.2369 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.6469 3.8374 0.3293 C 0 0 0 0 0 0 0 0 0 0 0 0 0.1402 4.9295 0.2663 N 0 0 0 0 0 0 0 0 0 0 0 0 1.4514 4.6888 0.0820 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0142 3.4245 -0.0345 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7096 3.3526 -0.3412 Cl 0 0 0 0 0 0 0 0 0 0 0 0 1.1766 2.2923 0.0532 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6244 0.9527 -0.0866 N 0 0 0 0 0 0 0 0 0 0 0 0 1.9402 0.6879 -1.4878 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0995 -0.8122 -1.6490 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1170 -1.3886 -0.6820 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0108 -2.9048 -0.6669 C 0 0 0 0 0 0 0 0 0 0 0 0 4.4324 -3.3901 -0.4643 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2501 -2.3238 -0.9715 N 0 0 0 0 0 0 0 0 0 0 0 0 4.5260 -1.1579 -1.1683 C 0 0 0 0 0 0 0 0 0 0 0 0 4.9598 -0.1052 -1.6058 O 0 0 0 0 0 0 0 0 0 0 0 0 2.9678 -0.8618 0.7386 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7574 0.6396 0.7759 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0191 0.3145 1.1346 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.9518 -0.7208 1.1756 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.9974 -3.0007 1.0874 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0721 -3.7590 0.8476 N 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 2 0 4 5 1 0 5 6 2 0 6 7 1 0 7 8 2 0 8 9 1 0 9 10 2 0 10 11 1 0 11 12 2 0 12 13 1 0 13 14 1 0 13 15 2 0 15 16 1 0 16 17 1 0 17 18 1 0 18 19 1 0 19 20 1 0 20 21 1 0 21 22 1 0 22 23 1 0 23 24 2 0 19 25 1 0 25 26 1 0 8 27 1 0 27 28 2 0 4 29 1 0 29 30 2 0 30 2 1 0 28 5 1 0 15 9 1 0 26 16 1 0 23 19 1 0 M END $$$$ | ||
ZINC299869731 | 0.73 | ZINC299869731 RDKit 3D 28 32 0 0 0 0 0 0 0 0999 V2000 -4.7478 3.5767 0.4036 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.5603 2.3387 -0.3210 N 0 0 0 0 0 0 0 0 0 0 0 0 -5.4219 2.0165 -1.2978 N 0 0 0 0 0 0 0 0 0 0 0 0 -4.9644 0.8380 -1.7331 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.8103 0.4164 -1.0367 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9550 -0.6945 -1.0822 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8584 -0.7725 -0.2063 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9710 -1.9466 -0.2340 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5500 -3.2152 -0.3380 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8882 -4.3895 -0.3661 N 0 0 0 0 0 0 0 0 0 0 0 0 0.4529 -4.2993 -0.2915 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1585 -3.1077 -0.1964 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8782 -3.2242 -0.1463 Cl 0 0 0 0 0 0 0 0 0 0 0 0 0.4460 -1.8877 -0.1661 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0620 -0.6060 -0.1084 N 0 0 0 0 0 0 0 0 0 0 0 0 1.8765 -0.4776 1.0979 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3062 0.9726 1.2194 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0071 1.4712 -0.0309 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1499 2.9846 0.0172 C 0 0 0 0 0 0 0 0 0 0 0 0 4.4612 3.2697 -0.6892 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2240 2.0648 -0.5219 N 0 0 0 0 0 0 0 0 0 0 0 0 4.4429 1.0085 -0.0767 C 0 0 0 0 0 0 0 0 0 0 0 0 4.8322 -0.1179 0.1873 O 0 0 0 0 0 0 0 0 0 0 0 0 2.2942 1.0741 -1.3159 C 0 0 0 0 0 0 0 0 0 0 0 0 1.8641 -0.3807 -1.3070 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6644 0.2699 0.7098 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.4978 1.3917 0.7841 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5665 1.4262 -0.1132 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 2 0 4 5 1 0 5 6 2 0 6 7 1 0 7 8 1 0 8 9 2 0 9 10 1 0 10 11 2 0 11 12 1 0 12 13 1 0 12 14 2 0 14 15 1 0 15 16 1 0 16 17 1 0 17 18 1 0 18 19 1 0 19 20 1 0 20 21 1 0 21 22 1 0 22 23 2 0 18 24 1 0 24 25 1 0 7 26 2 0 26 27 1 0 27 28 2 0 28 2 1 0 28 5 1 0 14 8 1 0 25 15 1 0 22 18 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
Single dose inhibition of SARS-CoV-2 cytopathic effect in VeroE6 | primary assay | Organism Severe acute respiratory syndrome-related coronavirus | inactive |
Single dose inhibition of SARS-CoV-2 3CL-Pro | primary assay | Replicase polyprotein 1ab | inactive |